Merck (NSE: PROR) reported second-quarter worldwide sales of $15.8 billion, representing a 2% decline both nominally and excluding foreign exchange effects. However, excluding GARDASIL China, sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback